Galera reports first quarter 2022 financial results and recent corporate updates

Company plans to submit a new drug application (nda) for avasopasem for the treatment of radiotherapy-induced severe oral mucositis (som) by end of 2022
GRTX Ratings Summary
GRTX Quant Ranking